Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Vibrating platform may improve balance and thinking in Parkinson's

NCT ID NCT07678983

Symptom relief Sponsor: Izmir Bakircay University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 15, 2026 · Updated 3 times

Summary

This study investigates whether whole-body vibration (WBV) therapy, added to standard exercise, can improve balance, walking, thinking, and the ability to do two things at once in people with Parkinson's disease. Participants will be randomly assigned to receive either low-frequency or medium-frequency WBV during supervised exercise sessions twice a week for eight weeks. The goal is to see if different vibration frequencies offer different benefits for movement and cognition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Whole Body Vibration (WBV) therapy
What this could lead to
If effective, WBV could become a simple, drug-free way to help people with Parkinson's move better and think more clearly during daily tasks.
What could go wrong
This is a small, early-stage trial with 66 participants, so results may not apply to everyone. The benefits, if any, might be modest and not outweigh the effort of twice-weekly sessions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Jan 2026

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Individuals aged 30-80 years with a clinical diagnosis of Parkinson's disease. Hoehn and Yahr stages 1-3. * Stable medical treatment (no changes in medication for the past 4 weeks). * Willingness to participate and provision of written informed consent. * Score of 24 or higher on the Standardized Mini Mental State Examination (SMMSE). Exclusion Criteria * Advanced stage Parkinson's disease (Hoehn and Yahr stage \>3) or presence of severe motor complications. * History of surgical interventions or other neurological/vestibular disorders that may affect balance and gait (E.G., stroke, epilepsy, peripheral neuropathy). * Presence of severe cardiovascular or respiratory conditions that may affect stability (E.G., heart failure, uncontrolled hypertension, advanced COPD). * Conditions contraindicating whole-body vibration (WBV) application (E.G., severe osteoporosis, active thrombosis). * Psychiatric disorders or major depression that may interfere with treatment participation. * Significant communication or language impairments affecting participation. Withdrawal Criteria * Voluntary withdrawal from the study. * Development of health problems during the intervention that prevent completion of the study (E.G., unexpected acute illness or temporary medical condition). * Changes in medication or medical status during the study that may affect participation or performance. * Non-adherence to the protocol (attendance rate below 80% of sessions).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Balance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gait apraxia Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Balance Cognitive function Dual-task performance GAIT Parkinson's disease Reaction time

Contacts and locations

Locations

  • Izmir Bakircay University Cigli Training and Research Hospital

    Izmir, 35610, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.